Cardinal Health Investing Activities - Other 2010-2025 | CAH
Cardinal Health annual/quarterly investing activities - other history and growth rate from 2010 to 2025. Investing activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the investing activities section of the Cash Flows Statement
- Cardinal Health investing activities - other for the quarter ending March 31, 2025 was $0M, a 100% decline year-over-year.
- Cardinal Health investing activities - other for the twelve months ending March 31, 2025 was $0M, a 100% decline year-over-year.
- Cardinal Health annual investing activities - other for 2024 was $0B, a 0% decline from 2023.
- Cardinal Health annual investing activities - other for 2023 was $0B, a 0% decline from 2022.
- Cardinal Health annual investing activities - other for 2022 was $0B, a 0% decline from 2021.
Cardinal Health Annual Investing Activities - Other (Millions of US $) |
2024 |
$N/A |
2023 |
$N/A |
2022 |
$N/A |
2021 |
$N/A |
2020 |
$N/A |
2019 |
$N/A |
2018 |
$N/A |
2017 |
$N/A |
2016 |
$N/A |
2015 |
$N/A |
2014 |
$N/A |
2013 |
$N/A |
2012 |
$N/A |
2011 |
$N/A |
2010 |
$-10 |
2009 |
$-129 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$36.816B |
$226.827B |
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
|